Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers Tenders > Headlines for 2014 > News item |
Valeant calls in full $500 million 6¾% notes for Oct. 15 redemption
By Jennifer Chiou
New York, Sept. 15 – Valeant Pharmaceuticals International Inc. announced that it will redeem all $500 million aggregate principal amount of its 6¾% senior notes due 2017.
The redemption date is Oct. 15.
The Bank of New York Mellon Trust Co., NA is the trustee.
Valeant is a specialty pharmaceutical company with U.S. headquarters in Bridgewater, N.J., and international headquarters in Laval, Quebec.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.